BioSpace

PharmaLogic buys Lantheus plant to build transatlantic radiopharmaceutical CDMO

Less than two years after acquiring the assets, Lantheus is selling its CDMO unit and a New Jersey production plant to PharmaLogic.

By BioSpace

1 min read
PharmaLogic buys Lantheus plant to build transatlantic radiopharmaceutical CDMO
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech